The newest generation of GLP-1 drugs are being hailed by some as “miracle drugs” for the treatment of obesity. But GLP-1s are expensive, insurance coverage is limited, and not everyone with obesity can and or wants to take them. In this episode, which is based on Goldman Sachs Research’s latest Top of Mind report, obesity medicine physician Dr. Fatima Cody Stanford and Jonathan Gruber, professor of economics and chairman of the Economics Department at MIT, discuss how large the addressable market for GLP-1s actually is and the implications for US fiscal health.
If you want more insights from Goldman Sachs, make sure to visit GS.com and sign up for Briefings, a weekly newsletter from Goldman Sachs about trends spanning markets, industries, and the global economy.
Is the UK economy finally turning the corner?
Why Treasury auctions — and rising deficits — are becoming a focal point for markets and investors
Are inflation fears overblown? The outlook for inflation, US growth, and long-term rates
Global insurers turn to private credit — and AI
Capital Group’s Rob Lovelace on long-term investing, succession planning, and leadership lessons
Are the largest US stocks too dominant?
Global transit & trade: in rough waters
High mortgage rates, limited inventory continue to challenge the US housing market
What’s ahead for retail: how retail CEOs are navigating a more complex environment
Beyond roads, bridges, and tunnels: the megatrends shaping infrastructure investments
Dimensional’s Founder and Chairman David Booth on being an index pioneer, working with Nobel laureates, and investing through uncertainty
Shifting supply and demand dynamics buffer oil market
2024: the year of elections
Investing in a post-modern ‘super cycle’
The Future of Four Wheels: Episode 4, How a New Kind of Car Will Change Our World
The Future of Four Wheels: Episode 3, The New New-Car Business
The Future of Four Wheels: Episode 2, Building the Car of the Future
The Future of Four Wheels: Episode 1, The Twin Revolution
Goldman Sachs Chairman and CEO David Solomon on the global economy, the deal-making environment, and the firm’s strategic priorities
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
TED Radio Hour
FT Alphachat
Freakonomics Radio
Stephanomics
Odd Lots